Eintrag weiter verarbeiten
A case of beta-thalassaemia major resistant to standard treatment
Gespeichert in:
| Zeitschriftentitel: | Clinical Management Issues |
|---|---|
| Personen und Körperschaften: | , , , , , , |
| In: | Clinical Management Issues, 4, 2010, 2, S. 65-70 |
| Format: | E-Article |
| Sprache: | Unbestimmt |
| veröffentlicht: |
Seed SRL
|
| Schlagwörter: |
| author_facet |
Masera, Nicoletta Decimi, Valentina Tavecchia, Luisa Capra, Marietta Cazzaniga, Giovanni Biondi, Andrea Masera, Giuseppe Masera, Nicoletta Decimi, Valentina Tavecchia, Luisa Capra, Marietta Cazzaniga, Giovanni Biondi, Andrea Masera, Giuseppe |
|---|---|
| author |
Masera, Nicoletta Decimi, Valentina Tavecchia, Luisa Capra, Marietta Cazzaniga, Giovanni Biondi, Andrea Masera, Giuseppe |
| spellingShingle |
Masera, Nicoletta Decimi, Valentina Tavecchia, Luisa Capra, Marietta Cazzaniga, Giovanni Biondi, Andrea Masera, Giuseppe Clinical Management Issues A case of beta-thalassaemia major resistant to standard treatment Business, Management and Accounting (miscellaneous) Medicine (miscellaneous) |
| author_sort |
masera, nicoletta |
| spelling |
Masera, Nicoletta Decimi, Valentina Tavecchia, Luisa Capra, Marietta Cazzaniga, Giovanni Biondi, Andrea Masera, Giuseppe 2283-3137 1973-4832 Seed SRL Business, Management and Accounting (miscellaneous) Medicine (miscellaneous) http://dx.doi.org/10.7175/cmi.v4i2.531 <jats:p>We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the occurrence of severe, acute, post-transfusional reactions. After 10 years of treatment, she failed to respond to hydroxyurea. When she received thalidomide, haemoglobin levels increased from 3.7 g/dl to 9 g/dl. Since then, at 22 months of follow-up, the therapy is still effective and well tolerated. The case gives the opportunity to describe the clinical use of thalidomide, and its potential in the management of beta-thalassaemia.</jats:p> A case of beta-thalassaemia major resistant to standard treatment Clinical Management Issues |
| doi_str_mv |
10.7175/cmi.v4i2.531 |
| facet_avail |
Online Free |
| finc_class_facet |
Wirtschaftswissenschaften Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNzE3NS9jbWkudjRpMi41MzE |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNzE3NS9jbWkudjRpMi41MzE |
| institution |
DE-15 DE-Rs1 DE-Pl11 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 |
| imprint |
Seed SRL, 2010 |
| imprint_str_mv |
Seed SRL, 2010 |
| issn |
2283-3137 1973-4832 |
| issn_str_mv |
2283-3137 1973-4832 |
| language |
Undetermined |
| mega_collection |
Seed SRL (CrossRef) |
| match_str |
masera2010acaseofbetathalassaemiamajorresistanttostandardtreatment |
| publishDateSort |
2010 |
| publisher |
Seed SRL |
| recordtype |
ai |
| record_format |
ai |
| series |
Clinical Management Issues |
| source_id |
49 |
| title |
A case of beta-thalassaemia major resistant to standard treatment |
| title_unstemmed |
A case of beta-thalassaemia major resistant to standard treatment |
| title_full |
A case of beta-thalassaemia major resistant to standard treatment |
| title_fullStr |
A case of beta-thalassaemia major resistant to standard treatment |
| title_full_unstemmed |
A case of beta-thalassaemia major resistant to standard treatment |
| title_short |
A case of beta-thalassaemia major resistant to standard treatment |
| title_sort |
a case of beta-thalassaemia major resistant to standard treatment |
| topic |
Business, Management and Accounting (miscellaneous) Medicine (miscellaneous) |
| url |
http://dx.doi.org/10.7175/cmi.v4i2.531 |
| publishDate |
2010 |
| physical |
65-70 |
| description |
<jats:p>We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the occurrence of severe, acute, post-transfusional reactions. After 10 years of treatment, she failed to respond to hydroxyurea. When she received thalidomide, haemoglobin levels increased from 3.7 g/dl to 9 g/dl. Since then, at 22 months of follow-up, the therapy is still effective and well tolerated. The case gives the opportunity to describe the clinical use of thalidomide, and its potential in the management of beta-thalassaemia.</jats:p> |
| container_issue |
2 |
| container_start_page |
65 |
| container_title |
Clinical Management Issues |
| container_volume |
4 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792323689220407299 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:37:31.517Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+case+of+beta-thalassaemia+major+resistant+to+standard+treatment&rft.date=2010-06-15&genre=article&issn=1973-4832&volume=4&issue=2&spage=65&epage=70&pages=65-70&jtitle=Clinical+Management+Issues&atitle=A+case+of+beta-thalassaemia+major+resistant+to+standard+treatment&aulast=Masera&aufirst=Giuseppe&rft_id=info%3Adoi%2F10.7175%2Fcmi.v4i2.531&rft.language%5B0%5D=und |
| SOLR | |
| _version_ | 1792323689220407299 |
| author | Masera, Nicoletta, Decimi, Valentina, Tavecchia, Luisa, Capra, Marietta, Cazzaniga, Giovanni, Biondi, Andrea, Masera, Giuseppe |
| author_facet | Masera, Nicoletta, Decimi, Valentina, Tavecchia, Luisa, Capra, Marietta, Cazzaniga, Giovanni, Biondi, Andrea, Masera, Giuseppe, Masera, Nicoletta, Decimi, Valentina, Tavecchia, Luisa, Capra, Marietta, Cazzaniga, Giovanni, Biondi, Andrea, Masera, Giuseppe |
| author_sort | masera, nicoletta |
| container_issue | 2 |
| container_start_page | 65 |
| container_title | Clinical Management Issues |
| container_volume | 4 |
| description | <jats:p>We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the occurrence of severe, acute, post-transfusional reactions. After 10 years of treatment, she failed to respond to hydroxyurea. When she received thalidomide, haemoglobin levels increased from 3.7 g/dl to 9 g/dl. Since then, at 22 months of follow-up, the therapy is still effective and well tolerated. The case gives the opportunity to describe the clinical use of thalidomide, and its potential in the management of beta-thalassaemia.</jats:p> |
| doi_str_mv | 10.7175/cmi.v4i2.531 |
| facet_avail | Online, Free |
| finc_class_facet | Wirtschaftswissenschaften, Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuNzE3NS9jbWkudjRpMi41MzE |
| imprint | Seed SRL, 2010 |
| imprint_str_mv | Seed SRL, 2010 |
| institution | DE-15, DE-Rs1, DE-Pl11, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4 |
| issn | 2283-3137, 1973-4832 |
| issn_str_mv | 2283-3137, 1973-4832 |
| language | Undetermined |
| last_indexed | 2024-03-01T11:37:31.517Z |
| match_str | masera2010acaseofbetathalassaemiamajorresistanttostandardtreatment |
| mega_collection | Seed SRL (CrossRef) |
| physical | 65-70 |
| publishDate | 2010 |
| publishDateSort | 2010 |
| publisher | Seed SRL |
| record_format | ai |
| recordtype | ai |
| series | Clinical Management Issues |
| source_id | 49 |
| spelling | Masera, Nicoletta Decimi, Valentina Tavecchia, Luisa Capra, Marietta Cazzaniga, Giovanni Biondi, Andrea Masera, Giuseppe 2283-3137 1973-4832 Seed SRL Business, Management and Accounting (miscellaneous) Medicine (miscellaneous) http://dx.doi.org/10.7175/cmi.v4i2.531 <jats:p>We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the occurrence of severe, acute, post-transfusional reactions. After 10 years of treatment, she failed to respond to hydroxyurea. When she received thalidomide, haemoglobin levels increased from 3.7 g/dl to 9 g/dl. Since then, at 22 months of follow-up, the therapy is still effective and well tolerated. The case gives the opportunity to describe the clinical use of thalidomide, and its potential in the management of beta-thalassaemia.</jats:p> A case of beta-thalassaemia major resistant to standard treatment Clinical Management Issues |
| spellingShingle | Masera, Nicoletta, Decimi, Valentina, Tavecchia, Luisa, Capra, Marietta, Cazzaniga, Giovanni, Biondi, Andrea, Masera, Giuseppe, Clinical Management Issues, A case of beta-thalassaemia major resistant to standard treatment, Business, Management and Accounting (miscellaneous), Medicine (miscellaneous) |
| title | A case of beta-thalassaemia major resistant to standard treatment |
| title_full | A case of beta-thalassaemia major resistant to standard treatment |
| title_fullStr | A case of beta-thalassaemia major resistant to standard treatment |
| title_full_unstemmed | A case of beta-thalassaemia major resistant to standard treatment |
| title_short | A case of beta-thalassaemia major resistant to standard treatment |
| title_sort | a case of beta-thalassaemia major resistant to standard treatment |
| title_unstemmed | A case of beta-thalassaemia major resistant to standard treatment |
| topic | Business, Management and Accounting (miscellaneous), Medicine (miscellaneous) |
| url | http://dx.doi.org/10.7175/cmi.v4i2.531 |